Intracellular signaling for vasoconstrictor coupling factor 6: Novel function of β-subunit of ATP synthase as receptor

Hypertension

Volumn 46, Issue 5, 2005, Pages 1140-1146

  Osanai, Tomohiro ^a   Magota, Koji ^b   Tanaka, Makoto ^a   Shimada, Michiko ^a   Murakami, Reiichi ^a   Sasaki, Satoko ^a   Tomita, Hirofumi ^a   Maeda, Naotaka ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b SUNTORY LTD   (Japan)

Author keywords

Hypertension; Prostacyclin

Indexed keywords

2',7' BIS(CARBOXYETHYL) 5(6) CARBOXYFLUORESCEIN; ADENOSINE DIPHOSPHATE; AMILORIDE; ANTIBODY; ARACHIDONIC ACID; CARBOXYFLUORESCEIN; CELL MEMBRANE PROTEIN; CHEMICAL AGENT; COUPLING FACTOR 6; EFRAPEPTIN; HYDROGEN; IODINE 125; PHOSPHOLIPASE A2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE INHIBITOR; RADIOLIGAND; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL PH; CELL SURFACE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; ENZYME SUBUNIT; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASOCONSTRICTION;

ARACHIDONIC ACID; CELLS, CULTURED; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOPRECIPITATION; INTRACELLULAR MEMBRANES; ISOENZYMES; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; OXIDATIVE PHOSPHORYLATION COUPLING FACTORS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; UMBILICAL VEINS; VASOCONSTRICTION;

EID: 27444439553     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000186483.86750.85     Document Type: Article

References (25)

1. Boyer PD. The ATP synthase-a splendid molecular machine. Annu Rev Biochem. 1997;66:717-749.
2. + transporting ATP synthase on the surface of tumor cell lines. J Exp Med. 1994;180:273-281.
3. Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, Champagne E, Pineau T, Georgeaud V, Walker JE, Terce F, Collet X, Perret B, Barbaras R. Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature. 2003;421:75-79.
4. 0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA. 2001;98:6656-6661.
5. 0 complexes. J Biol Chem. 1989;264:15548-15551.
6. Osanai T, Kamada T, Fujiwara N, Katoh T, Takahashi K, Kimura M, Satoh K, Magota K, Kodama S, Tanaka T, Okumura K. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem. 1998;273: 31778-31783.
7. Osanai T, Tanaka M, Kamada T, Nakano T, Takahashi K, Okada S, Sirato K, Magota K, Kodama S, Okumura K. Mitochondrial coupling factor 6 as a novel endogenous vasoconstrictor. J Clin Invest. 2001;108:1023-1030.
8. Osanai T, Okada S, Sirato K, Nakano T, Saitoh M, Magota K, Okumura K. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and released by shear stress. Circulation. 2001; 104:3132-3136.
9. Sasaki S, Osanai T, Tomita H, Matsunaga T, Magota K, Okumura K. Tumor necrosis factor áas an endogenous stimulator for circulating coupling factor 6. Cardiovasc Res. 2004;62:578-586.
10. 2 inhibit shear-induced coupling factor 6 release in endothelial cells. Cardiovasc Res. 2005;67:134-141.
11. 1 complex. Biochem Biophys Res Commun. 1999;261:499-503.
12. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest. 1989;83:708-712.
13. Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973;22: 3099-3108.
14. Abrahams JP, Leslie AG, Lutter R, Walker JE. Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria. Nature. 1994;370: 621-628.
15. Braig K, Menz RI, Montgomery MG, Leslie AG, Walker JE. Structure of bovine mitochondrial F(1)-ATPase inhibited by Mg(2+) ADP and aluminium fluoride. Structure Fold Des. 2000;8:567-573.
16. Menz RI, Walker JE, Leslie AG. Structure of bovine mitochondrial F(1)-ATPaSe with nucleotide bound to all three catalytic sites: implications for the mechanism of rotary catalysis. Cell. 2001;106:331-341.
17. Penefsky HS. Rate constants and equilibrium constants for the elementary steps of ATP hydrolysis by beef heart mitochondrial ATPase. Methods Enzymol. 1986;126:608-618.
18. Senior AE. Catalytic sites of Escherichia coli F1-ATPase. J Bioenerg Biomembr. 1992;24:479-484.
19. 2 isozymes in agonist-mediated signaling in proximal tubular epithelium. Hypertension. 1998;31:809-814.
20. 2 activity in lungs of sheep after smoke inhalation injury. Am J Physiol. 1999;277:L533-L542.
21. 2. Prostaglandins Other Lipid Mediat. 2003;71:217-234.
22. 2 activity: specific interaction model. FEBS Lett. 2001;489:243-248.
23. Ostrom RS, Gregorian C, Insel PA. Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J Biol Chem. 2000;275:11735-11739.
24. Osanai T, Sasaki S, Kamada T, Fujiwara N, Nakano T, Tomita H, Matsunaga T, Magota K, Okumura K. Circulating coupling factor 6 in human hypertension: role of reactive oxygen species. J Hypertens. 2003; 21:2323-2328.
25. Osanai T, Nakamura M, Sasaki S, Tomita H, Saitoh M, Osawa H, Yamabe H, Murakami S, Magota K, Okumura K. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int. 2003;64:2291-2297.